期刊文献+

老年MODS患者细胞因子的变化及临床意义 被引量:5

Clinical study of plasma cytokines in the elderly critical patients with multiple organ dysfunction syndrome
下载PDF
导出
摘要 目的 探讨肿瘤坏死因子α(TNF -α)、白细胞介素- 1β(IL - 1β)、白细胞介素- 6 (IL - 6 )、白细胞介素- 10 (IL- 10 )在老年多脏器功能障碍综合征(MODS)患者中的病理生理作用及其临床意义。方法 采用放射免疫法检测80例老年MODS患者的血清TNF -α、IL - 1β、IL - 6、IL - 10的动态变化。结果 老年MODS组的血清TNF -α、IL - 1β、IL - 6、IL - 10浓度较正常对照组明显升高(P <0 . 0 1) ,TNF -α、IL - 1β、IL - 6升高的峰值较IL - 10早,死亡组血清IL - 10浓度较存活组明显升高(P <0 . 0 1)。结论 细胞因子TNF -α、IL - 1β、IL - 6、IL - 10的异常释放参与了老年MODS的病理生理过程,选择不同时机以纠正细胞因子的失衡可能是今后的救治方向。 Objective To investigate the clinical significance and potential mechanism of plasma tumor necrosis factor (TNF-α), interleukin-1β(IL-1β),interleukin-6(IL-6),interleukin-10(IL-10)in the pathogenesis of multiple organ dysfunction syndrome(MODS) in the elderly critical patients.Methods The dynamic plasma levels of TNF-α,IL-1β,IL-6,IL-10 were measured in 80 MODS patients by using radioimmunoassay method.Results Plasma TNF-α,IL-1β,IL-6,IL-10 levels were significantly higher in MODS and SIRS group than those in healthy controls( P <0.01),the peak plasma levels of TNF-α,IL-1β,IL-6 reached more quickly than that of IL-10,Plasma IL-10 levels were significantly higher in dead group than those in survivors( P <0.01).Conclusions The abnormal release of TNF-α,IL-1β,IL-6,IL-10 play an important role in the pathophysiology of MODS with elderly patients.To maintain the balance of cytokines may be a method of treatment in future.
出处 《中国急救医学》 CAS CSCD 北大核心 2005年第5期318-319,共2页 Chinese Journal of Critical Care Medicine
基金 浙江省医药卫生科学研究基金资助项目 (No .2 0 0 0B0 19)
关键词 多脏器功能障碍综合征 细胞因子 老年人 Multiple organ dysfunction syndrome(MODS) Cytokines Elderly
  • 引文网络
  • 相关文献

参考文献7

  • 1姚咏明,盛志勇.MODS抗炎治疗研究的反思[J].中国危重病急救医学,1999,11(8):456-458. 被引量:74
  • 2邱海波,周韶霞,杨毅,黄英姿,郑瑞强.多器官功能障碍综合征的死亡危险因素分析及临床对策[J].中华急诊医学杂志,2001,10(1):13-16. 被引量:145
  • 3Panacek E, Marshall J, Fisehkoff S, et al. Neutralization of TNF by a monoclonal antibody improves survival and reduces organ dysfunction in human sepsis: results of the MONARCS trial [J]. Chest, 2000, 118(suppl.): 588.
  • 4Members of the American College of Chest Physicians/Society of Critical Care Medicine (ACCP/SCCM)consensus conference committee 1992.Definitions of sepsis and organ failure and guideline for the use of innovative therapies[J]. Crit Care Med, 1992,20:864.
  • 5Bone RC, Grodzin CJ, Balk RA. Sepsis: a new hypothesis for pathogenesis of the disease process[J]. Chest, 1997,121:235 - 243.
  • 6Adib - Conquy M, Moine P, Asehnoune K, et al. Tool - like receptormediated TNF and IL- 10 production are not similarly affected during systemic inflammation[J]. Am J Respir Crit Care Med, 2003,168:158 -164.
  • 7Gogos CA, Drosou E, Bassaris HP, et al. Pro- versus anti- inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options[J] .J Infect Dis, 2000,181( 1):176- 180.

二级参考文献1

共引文献216

同被引文献73

引证文献5

二级引证文献45

;
使用帮助 返回顶部